Greenshoe

Semrush Announces Pricing of Initial Public Offering

Retrieved on: 
Wednesday, March 24, 2021

Semrush Holdings, Inc. (Semrush), a leading online visibility management SaaS platform, today announced the pricing of its initial public offering of 10,000,000 shares of Class A common stock at an initial public offering price of $14.00 per share.

Key Points: 
  • Semrush Holdings, Inc. (Semrush), a leading online visibility management SaaS platform, today announced the pricing of its initial public offering of 10,000,000 shares of Class A common stock at an initial public offering price of $14.00 per share.
  • In addition, Semrush has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 Class A shares at the initial public offering price less the underwriting discount.
  • KeyBanc Capital Markets Inc. is also acting as a joint bookrunning manager for the proposed offering.
  • Semrush, with over 67,000 paying customers, is headquartered in Boston and has offices in Pennsylvania, Texas, Czech Republic, Cyprus, Poland and Russia.

Nuvei Announces Closing of US$552 Million Bought Deal Secondary Offering

Retrieved on: 
Wednesday, March 24, 2021

The Offering includes the partial exercise by the underwriters of their over-allotment option, as described below.

Key Points: 
  • The Offering includes the partial exercise by the underwriters of their over-allotment option, as described below.
  • Goldman Sachs Canada Inc., Credit Suisse, BMO Capital Markets and RBC Capital Markets acted as joint bookrunners for the Offering.
  • We are Nuvei (TSX: NVEI and NVEI.U), the global payment technology partner of thriving brands.
  • We provide the intelligence and technology businesses need to succeed locally and globally, through one integration propelling them further, faster.

Prothena Announces Pricing of Public Offering of 3,500,000 Ordinary Shares

Retrieved on: 
Wednesday, March 24, 2021

All of the ordinary shares in the offering were sold by Prothena.

Key Points: 
  • All of the ordinary shares in the offering were sold by Prothena.
  • In addition, Prothena has granted the underwriters a 30-day option to purchase up to an additional 525,000 of its ordinary shares.
  • Net proceeds to Prothena from the ordinary shares to be sold by Prothena in the offering are expected to be $67.8 million, after deducting the underwriting discount and estimated offering expenses, but excluding any exercise of the underwriters option to purchase additional ordinary shares.
  • The offering is expected to close on March 26, 2021, subject to customary closing conditions.

Prothena Announces Proposed Offering of Ordinary Shares

Retrieved on: 
Tuesday, March 23, 2021

All of the ordinary shares in the offering will be sold by Prothena.

Key Points: 
  • All of the ordinary shares in the offering will be sold by Prothena.
  • In addition, Prothena has granted the underwriters a 30-day option to purchase up to an additional15% of the number of ordinary shares sold.
  • The offering is subject to market conditions, and there can be no assurance as to whether or when the offering will be completed, or as to the actual size or terms of the offering.
  • These statements relate to, among other things, the timing and size of the proposed offering, the conditions affecting the capital markets, general economic, industry, or political conditions, and the satisfaction of customary closing conditions related to the proposed offering.

Frontier Announces Launch of Initial Public Offering

Retrieved on: 
Tuesday, March 23, 2021

DENVER, March 23, 2021 (GLOBE NEWSWIRE) -- Frontier Group Holdings, Inc. (Frontier) today announced the launch of its initial public offering of 30 million shares of its common stock.

Key Points: 
  • DENVER, March 23, 2021 (GLOBE NEWSWIRE) -- Frontier Group Holdings, Inc. (Frontier) today announced the launch of its initial public offering of 30 million shares of its common stock.
  • The offering consists of 15 million shares of common stock offered by Frontier and 15 million shares of common stock to be sold by certain of Frontiers existing stockholders.
  • A selling stockholder intends to grant the underwriters a 30-day option to buy an additional 4.5 million shares of common stock from such selling stockholder at the initial public offering price, less the underwriting discount and commissions.
  • The initial public offering price is currently expected to be between $19 and $21 per share.

Bilibili Announces Pricing of Global Offering

Retrieved on: 
Tuesday, March 23, 2021

SHANGHAI, China, March 23, 2021 (GLOBE NEWSWIRE) -- Bilibili Inc. (the Company or Bilibili) (Nasdaq: BILI), an iconic brand and a leading video community for young generations in China, today announced the pricing of the global offering (the Global Offering) of new 25,000,000 Class Z ordinary shares of the Company (the Offer Shares or Shares), which comprises an international offering (the International Offering) and a Hong Kong public offering (the Hong Kong Public Offering).

Key Points: 
  • SHANGHAI, China, March 23, 2021 (GLOBE NEWSWIRE) -- Bilibili Inc. (the Company or Bilibili) (Nasdaq: BILI), an iconic brand and a leading video community for young generations in China, today announced the pricing of the global offering (the Global Offering) of new 25,000,000 Class Z ordinary shares of the Company (the Offer Shares or Shares), which comprises an international offering (the International Offering) and a Hong Kong public offering (the Hong Kong Public Offering).
  • The final offer price for both the International Offering and the Hong Kong Public Offering (the Offer Price) has been set as HK$808.00 per Offer Share.
  • The gross proceeds to the Company from the Global Offering, before deducting underwriting fees and the offering expenses, are expected to be approximately HK$20,200 million (assuming the Overallotment Option is not exercised).
  • Bilibili builds its community around aspiring users, high-quality content, talented content creators and the strong emotional bond among them.

My Size, Inc. Prices $3.3 Million Underwritten Public Offering of Common Stock

Retrieved on: 
Tuesday, March 23, 2021

The proposed offering equates to 2,618,532 shares of the Companys common stock at a price of $1.26 per share.

Key Points: 
  • The proposed offering equates to 2,618,532 shares of the Companys common stock at a price of $1.26 per share.
  • The Company has also granted the underwriters a 45-day option to purchase up to an additional 15% of the number of shares of common stock offered in the public offering to cover over-allotments, if any, at the public offering price, which would total gross proceeds of approximately $3.8 million.
  • The offering is expected to close on or about March 25, 2021, subject to customary closing conditions.
  • Actual results to differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly.

TeraGo Announces Overnight Marketed Offering of Units

Retrieved on: 
Monday, March 22, 2021

TORONTO, March 22, 2021 (GLOBE NEWSWIRE) -- TeraGo Inc. (TeraGo or the Company) (TSX: TGO, www.terago.ca), has announced today that it has commenced an overnight marketed offering of units (the "Units") for gross proceeds of approximately $15 million (the "Offering").

Key Points: 
  • TORONTO, March 22, 2021 (GLOBE NEWSWIRE) -- TeraGo Inc. (TeraGo or the Company) (TSX: TGO, www.terago.ca), has announced today that it has commenced an overnight marketed offering of units (the "Units") for gross proceeds of approximately $15 million (the "Offering").
  • TeraGo has granted the Underwriters an over-allotment option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the total number of Units, Shares and/or Warrants or any combination thereof sold under the Offering to cover over-allotments, if any (the Over-Allotment Option).
  • The Offering will be priced in the context of the market with the price and other final terms to be determined at the time of entering into an underwriting agreement for the Offering.
  • Closing of the Offering will be subject to customary closing conditions, including listing of the Shares on the Toronto Stock Exchange and all required approvals.

Exagen Inc. Announces Proposed Public Offering of Common Stock

Retrieved on: 
Monday, March 22, 2021

SAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN),a leading provider of autoimmune testing solutions, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Key Points: 
  • SAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN),a leading provider of autoimmune testing solutions, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.
  • In addition, Exagen intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.
  • All of the shares to be sold in the offering are to be sold by Exagen.
  • There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Verrica Announces Proposed Public Offering of Common Stock

Retrieved on: 
Monday, March 22, 2021

All of the shares of common stock to be sold in the offering will be offered by Verrica.

Key Points: 
  • All of the shares of common stock to be sold in the offering will be offered by Verrica.
  • Verrica also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering on the same terms and conditions.
  • The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
  • A shelf registration statement relating to the shares of common stock offered in the public offering described above was filed with theSecurities and Exchange Commission(SEC) onMarch 13, 2020 and declared effective by the SEC on March 25, 2020.